Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


123>>>
71 Items
Title  Creator  Group name  Publishing year 
RIP140 regulates POLK gene expression and the response to alkylating drugs in colon cancer cells Palassin et al. EquipeVC 2022
RIP140 inhibits glycolysis-dependent proliferation of breast cancer cells by regulating GLUT3 expression through transcriptional crosstalk between hypoxia induced factor and p53 Jacquier et al. EquipeVC 2022-05-03
Endogenous Retroviral Sequences Behave as Putative Enhancers Controlling Gene Expression through HP1-Regulated Long-Range Chromatin Interactions Calvet et al. EquipeVC 2022-08-03
Metastatic colorectal cancer cells maintain the TGF? program and use TGFBI to fuel angiogenesis Chiavarina et al. EquipeVC 2021
Fabrication of 3D printed antimicrobial polycaprolactone scaffolds for tissue engineering applications Radhakrishnan et al. EquipeVC 2021-01
A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors Palassin et al. EquipeVC 2021-09-03
Letter on 'Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial' Kalmanovich et al. EquipeVC 2020-03
Hypoglycemia While Driving in Insulin-Treated Patients: Incidence and Risk Factors Lohan et al. EquipeVC 2020-08-07
Development of new biocompatible 3D printed graphene oxide-based scaffolds Belaid et al. EquipeVC 2020-05
Cytoplasmic PPAR? is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers Shao et al. EquipeVC 2020-02-21
Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor ?1 Are Inversely Associated with Survival in Primary Breast Cancer Shao et al. EquipeVC 2020-01-03
Collaboration between cardiologist and clinical pharmacist on prescription quality: What is the potential clinical impact for cardiology patients? Audurier et al. EquipeVC 2020-09
Adverse Drug Events Detected by Clinical Pharmacists in an Emergency Department: A Prospective Monocentric Observational Study Laureau et al. EquipeVC 2020-03-12
The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status Jeschke et al. EquipeVC Feb 26, 2019
Regulation of RXR-RAR Heterodimers by RXR- and RAR-Specific Ligands and Their Combinations le Maire et al. EquipeVC 2019-11-05
Prognostic relevance of RIP140 and ER? expression in unifocal versus multifocal breast cancers: a preliminary report Müller et al. EquipeVC Jan 18, 2019
Increased expression of the HDAC9 gene is associated with antiestrogen resistance of breast cancers Linares et al. EquipeVC 2019-07
Clinical, Economic, and Organizational Impact of the Clinical Pharmacist in an Orthopedic and Trauma Surgery Department Renaudin et al. EquipeVC 2019
Transcriptional regulation of the intestinal cancer stem cell phenotype Gleizes et al. EquipeVC 2018
Non-achievement of LDL-cholesterol targets in patients with diabetes at very-high cardiovascular risk receiving statin treatment: Incidence and risk factors Breuker et al. EquipeVC Oct 01, 2018
Importance of RIP140 and LCoR Sub-Cellular Localization for Their Association With Breast Cancer Aggressiveness and Patient Survival Sixou et al. EquipeVC Oct 2018
Imidazo[2,1-b]benzothiazol Derivatives as Potential Allosteric Inhibitors of the Glucocorticoid Receptor Christodoulou et al. EquipeVC Apr 12, 2018
Gender Dysphoria and Gender Change in Disorders of Sex Development/Intersex Conditions: Results From the dsd-LIFE Study Kreukels et al. EquipeVC May 2018
Family History is Underestimated in Children with Isolated Hypospadias: A French Multicenter Report of 88 Families Ollivier et al. EquipeVC 10 2018
Evaluation of the sST2-guided optimization of medical treatments of patients admitted for heart failure, to prevent readmission: Study protocol for a randomized controlled trial Curinier et al. EquipeVC 03 2018
123>>>
71 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés